Lawsuit: Washington state AG alleges stem cell center ‘deceptively’ marketed treatments for COVID-19

A company that runs the Seattle Stem Cell Center in the city’s lower Queen Anne neighborhood is facing a lawsuit from the state’s attorney general Bob Ferguson. His office announced the lawsuit Tuesday against US Stemology and its owner Tami Meraglia for “deceptively marketing stem cell treatments for COVID-19 and dozens of other serious medical conditions,” including asthma and congestive heart failure. The company charged 107 people a total of $748,250 for the “unsubstantiated” treatments, according to the office’s press release. The company’s website says it longer operates in Seattle but invites customers to call to learn about “stem cell treatments available outside the U.S.A.”